Pharma companies against plan to bring nutraceuticals under drug regulator
Controversy arises as government considers shifting nutraceuticals to drug regulatory authority from FSSAI oversight. Industry experts express reservations and call for detailed discussions. Nutraceutical segment set to reach $18 billion in India ...
Nutraceuticals refers to food products with extra health benefits and includes supplements, functional foods and beverages. According to industry data, the segment is projected to grow to $18 billion in India by the end of 2025 from $4 billion in 2020.
Experts said the regulations for nutraceuticals in the country are aligned with Codex Alimentarius, a global body functioning under the auspices of the World Health Organisation (WHO) to ensure safety of consumers.
The FSSAI regulations are similarly in sync with global practices and comparable with those prevailing in other countries such as the US, UK, Australia, China, Japan and those in the EU, they said.
"All these countries' regulations include the very same categories as under the FSSAI in their regulations, including, vitamins, minerals, pre- and probiotics," said Dr RK Sanghavi, chairman, Nutraceutical Committee of Indian Drug Manufacturers' Association (IDMA). He said the FSSAI has aligned India's nutraceuticals with global practices, thus ensuring safety of these products.

"A meeting was held with industry experts in April, and thereafter government officials have been having discussions among themselves. Not enough discussions have been held with us and hence we don't know what's happening on the issue," said another expert, who did not wish to be identified.
Sanghvi said even if only vitamins and minerals are to be shunted out from under the FSSAI, the nutraceutical market will shrink by 70%.
The government is also considering bringing nutraceuticals under price control, to make them more affordable for consumers.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.